Dillistone Group PLC Directorate Declaration

RNS Number : 1035I

Dillistone Group PLC

09 May 2025

 

 

9 May 2025 

 

Dillistone Group Plc 

("Dillistone" or the "Company") 

 

Directorate Declaration 

 

Dillistone Group Plc, the AIM quoted supplier of software and services for recruiters, has been notified by Julie Pomeroy, a non-executive Director of the Company, that Oxford Cannabinoid Technologies Holdings plc, a company of which she is a non-executive director, entered into administration on 2 May 2025.

 

This announcement is being disclosed pursuant to Rule 17 and Schedule 2, Paragraph (G) of the AIM Rules for Companies. 

 

 

 

 

Enquiries: 

 

Dillistone Group Plc
Giles Fearnley		Chairman	01256 297 000
Jason Starr		Chief Executive Officer
Ian Mackin		Finance Director
Zeus (Nominated adviser)
Mike Coe		Director, Investment Banking	020 3829 5000

 

 

Notes to Editors:  

 

Dillistone Group Plc is a leader in the supply and support of software and services to the recruitment industry. Dillistone operates through the Ikiru People (www.IkiruPeople.com) brand. 

 

The Group develops, markets and supports the Talentis, FileFinder, Infinity, Mid-Office, ISV and GatedTalent products. 

 

Dillistone was admitted to AIM, a market operated by the London Stock Exchange plc, in June 2006.   

 

Learn about our products: 

Talentis Software:                                  https://www.talentis.global/recruitment-software/ 

Voyager Software:                                 https://www.voyagersoftware.com 

GatedTalent Executive Jobs:      https://www.talentis.global/all-jobs 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

RDNFLFFIEAIAIIE